Special MVEC podcast series: COVID19 Road to a vaccine
The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.
In our first few episodes, we will be talking with vaccine experts Emeritus Professor Stanley Plotkin, Professor Kathryn Edwards and Professor Andrew Pollard.
Listen via our 播客页面 or subscribe below on your preferred podcast platform:
喇叭 - Apple podcasts - Spotify podcasts
Who's leading the race? A guide to coronavirus vaccines in the pipeline
This article from the ABC takes a closer look at some of the candidates in the race to making an effective SARS-CoV-2 vaccine. It looks at the ten vaccines currently in human trials (as at May 24, 2020).
Different kinds of vaccines in development are also discussed, both an experimental genetic vaccine as well as a viral vector vaccine; and which stage of trials these vaccines are currently at.
在这里阅读更多内容：
ABC: Who's leading the race? A guide to coronavirus vaccines in the pipeline
Stay tuned for our latest podcast series launching this week, COVID19 Road to a vaccine. Associate Professor Nigel Crawford, Director of SAEFVIC, will be discussing the different steps involved in creating a new vaccine with global vaccine experts.
Hepatitis A outbreak in Victoria
There is an ongoing hepatitis A outbreak in Victoria largely among people use drugs (primarily by injection) and people experiencing homelessness. According to the Department of Health, as of the 6th May 2020, there have been 56 confirmed cases and 6 possible cases associated with this outbreak since mid 2019.
In order to control this outbreak a hepatitis A vaccination program targeting affected people groups (people who use drugs and those experiencing homelessness) will be available until the 31st August, 2020.
Hepatitis B vaccine should also be offered as hepatitis B and C have a high rate of prevalence among people who inject drugs. Influenza vaccine should also be offered.
Read the full Department of Health advisory here: Hepatitis A outbreak
New NCIRS resource - Influenza vaccination during COVID-19 - FAQs for Aboriginal and Torres Strait Islander people
Aboriginal and Torres Strait Islander people are at an increased risk of serious disease when they contract influenza. During the current COVID-19 pandemic, it is more important than ever that Aboriginal Torres Strait Islander people are accessing an influenza vaccine. The influenza vaccine is funded under the National Immunisation Program for all Aboriginal and Torres Strait Islander people aged 6-months and over.
NCIRS have created a new FAQ resource addressing questions most frequently asked by people in the Aboriginal and Torres Strait Islander community:
NCIRS: Influenza vaccination during COVID-19 - FAQs for Aboriginal and Torres Strait Islander people
Are children with asthma at a greater risk of severe disease with COVID-19?
The Murdoch Children’s Research Institute (MCRI) are conducting extensive research into why children are more mildly affected by COVID-19. They are also investigating whether chronic health conditions such as asthma increase the risk of severe disease.
Read more about how children with asthma may be affected by COVID-19 at the link below:
MCRI: COVID-19 and asthma: what are the risks for children?
COVID-19 大流行期间维持免疫服务的 ATAGI 指导原则
Immunisation remains an essential service during the COVID-19 pandemic and it is very important immunisation providers maintain routine immunisation services whilst complying with measures to reduce the risk of transmission of COVID-19.
If scheduled vaccines are missed or delayed and the overall vaccination coverage rates drop, the risk of a resurgence of a well-controlled vaccine preventable disease like measles is increased. If this happens during or after the current pandemic, it places further stress on the health care system.
With this in mind, ATAGI (Australian Technical Advisory Group on Immunisation) have released guiding principles on maintaining immunisation services during the COVID-19 pandemic:
ATAGI: Guiding principles for maintaining immunisation services during the COVID-19 pandemic
流感疫苗和鸡蛋过敏
Based on prospective and retrospective studies of influenza vaccination in those with and without egg allergy (including egg anaphylaxis), the presence of egg allergy does not increase the risk of allergic reactions to the influenza vaccine and can be administered in a community immunisation setting, as a single dose, followed by the recommended 15 minute observation period.
For further information please see the following:
新的澳大利亚免疫手册应用程序
The Australian Immunisation Handbook is now available in an app! It can be downloaded from the App Store or Google Play.
Download Instructions:
- Search for "Immunisation Handbook" in either of the above app stores on the device you wish to add the Handbook App.
- Select the Australian Immunisation Handbook App. (Depending on your device, this may have either “Australian Department of Health” or “Medical” as the sub-header.)
- Click the Download icon to start.
- When the download is finished, you can open the App.
- The first time you open the App it will take approximately 1-2 minutes. (This is to store all the data into your device.)
通过我们的测验测试您的 2020 年流感疫苗知识！
We have developed a short quiz about the available 2020 influenza vaccines! Check your knowledge of the 2020 influenza recommendations and vaccines here:
MVEC 2020 Influenza vaccine quiz
Our 2020 influenza vaccine resources can be found here:
- 我如何知道在 2020 年流感季节使用哪个流感品牌？
- MVEC influenza vaccine recommendations 2020
- MVEC Influenza vaccine: frequently asked questions
世界免疫周 2020 年 4 月 24 日至 30 日
这是世界免疫周！
世界免疫周（WIW）的目的是促进疫苗的使用，以保护所有年龄段的人免受疾病侵害。每年，免疫接种可以挽救数百万人的生命，它被广泛认为是最成功和最具成本效益的健康干预措施之一。然而，全球仍有近 2000 万儿童未接种疫苗或疫苗接种不足。
作为疫苗安全网络（世界卫生组织建立的全球网站网络）的自豪成员，MVEC 很高兴庆祝 WIW。加入我们 Facebook
Instagram的 我们庆祝 WIW 的主题是 #VaccinesWork for All，重点关注开发、提供和接受疫苗的人们。在此阅读有关 WIW 的更多信息：